DELRAY BEACH, FL., November 7, 2024 /PRNewswire/ — The global periodontal disease treatment market is expected to arrive 3.63 billion US dollars to 2030 from 2.58 billion US dollars in 2024, growing at a CAGR of 5.9% during the forecast period 2024-2030. In all regions, the regulatory environment of periodontal disease treatment focuses primarily on safety and efficacy issues regarding therapeutic products and procedures. In the United Statesdental devices—including dental implants, lasers, and more—are controlled by the Food and Drug Administration (FDA), which certifies that they meet strict safety standards before being marketed. Such drugs, again, which include antibiotics and antiseptics, the FDA requires clinical evidence to demonstrate the effectiveness of such drugs in reducing periodontal pathogens, with secondary inflammation.
In the European region, the legal system for medicines is the European Medicines Agency (EMA) and devices under the Medical Device Regulation (MDR). The EMA has been careful to ensure that drugs for periodontal disease are checked not only for their benefits but also for their risks. Instead, the MDR has set stricter guidelines after 2021, with enhanced safety surveillance for dental devices.
In other countries incl Japan and Indiabodies such as PMDA and CDSCO monitor the approval processes of periodontal treatments. Local standards imposed by these agencies must meet international requirements, especially in advanced therapeutic practices involving the use of biomaterials and devices that assist in minimally invasive surgical procedures.
Based on the type of disease, the periodontal disease treatment market is segmented into Gingivitis, acute periodontitis, aggressive periodontitis and others. Among these, gingivitis holds the largest share in the periodontal disease treatment market in 2023. Gingivitis treatment market share is significant in the broader periodontal disease treatment market due to the high prevalence of gingivitis worldwide. Gingivitis is a mild form of periodontal disease and affects a large percentage of the population mainly due to poor oral hygiene, lifestyle such as smoking and health conditions including diabetes. This high incidence naturally creates a high demand for preventive and therapeutic products such as antiseptic mouthwashes, special toothpastes and teeth scaling procedures.
Based on the type of treatment, the periodontal disease treatment market is segmented into non-surgical treatment, flap surgery, soft tissue grafting, bone grafting, guided tissue regeneration and other treatments. Among these, the non-surgical treatment segment holds the largest share in the periodontal disease treatment market.
In 2023, non-surgical treatments hold the largest share in the treatment of periodontal disease due to several different factors, including patient preference for less invasive options, faster recovery, and cost effectiveness. In general, non-surgical intervention such as scaling and root planing (deep cleaning), antimicrobial agents, and laser therapy are usually the first line of defense for managing periodontal disease discovered in its early stages. These treatments will control infection, remove plaque and tartar from below the gum line, and promote healing without the need for surgery.
Request sample pages:
Key players in the authentication and brand protection market are – DENTSPLY SIRONA Inc. (USA), Envista Holdings Corporation (USA), A-dec Inc. (USA), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (USA), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (USA), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (USA), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (USA), PreXion, Inc. (Japan), Brasseler USA (USA), AMD Lasers (USA) and Bien-Air Dental (USA). These players are focusing on developing innovative authentication and brand protection technologies and offerings due to the emergence of new application areas for authentication and brand protection. These players not only have a diverse and comprehensive product portfolio but also have a strong geographical presence. These companies offer various product offerings and have operations around the world. They rely on their diversified product and R&D capabilities and service portfolios to increase their market share. These companies focus on contracting product launches, acquisitions, collaborations and partnerships to strengthen their footprint through product innovations and expand their business reach.
DENTSPLY SIRONA INC:
DENTSPLY SIRONA Inc. is a key market player in the global dental care market and plays a major role in the periodontal disease treatment market. The company provides a variety of innovative dental solutions. Among these solutions, the company has a specific line of products for the care of periodontal diseases. Taking into account the advances in technologies and thus a comprehensive product portfolio, Dentsply Sirona provides solutions for periodontal scaling, root planning and maintenance therapy, which are critical for the effective management of periodontal diseases.
Dentsply Sirona will continue to play an increasingly vital role in advancing treatment options for periodontal treatments, enhancing patient outcomes and supporting dental professionals in achieving effective and efficient work through its strong global distribution network, strategic partnerships and focus research and development.
INSTITUT STRAUMANN AG (SWITZERLAND):
Institut Straumann, a world leader in dental implantology and restorative dentistry, has been actively involved in the periodontal disease treatment market. The company offers a range of innovative solutions, including regenerative products, which are designed to enhance periodontal regeneration and promote healing in patients with periodontal disease. Straumann’s portfolio includes biomaterials such as bone grafts and membranes, which are critical in periodontal procedures to restore lost bone and tissue.
HENRY SCHEININC. (USA):
Henry Shine is an American company and a Fortune World’s Most Admired Company. It is the largest distributor of health products and services in the world, with a presence in 32 countries. The company supplies a wide range of animal health, medical and dental products to office-based healthcare professionals. They also offer equipment financing, practice management software and other value-added services. Henry Shine is one of the leading players in the periodontal disease treatment market, offering a range of products and services to help the dentist manage periodontal disease. Among the world’s largest distributors of dental supplies, Henry Shine gives the dentist advanced instruments for his practice. These include dental lasers, scaling instruments and other regenerative materials included in all periodontal treatments. In addition, the company maintains a comprehensive portfolio of pharmaceutical and diagnostic products that assist in the early detection and treatment of periodontal disease.
In addition to supplying products, by Henry Syne The focus on dental education and training has created great relevance for the company in this market. All the possible means of continuing education programs, workshops and online resources through which a dentist can obtain all the information about the latest trends and best treatment practices of periodontal care allow Henry Shine to become a single solution that can help both general dentists and periodontists achieve effective treatment outcomes for patients suffering from periodontal disease.
MarketsandMarkets™ has been recognized as one of the America’s Best Management Consulting Firms by Forbesaccording to their recent report.
MarketsandMarkets™ is a blue ocean alternative to development consulting and program management, leveraging a human-machine that delivers the supernatural growth boost for forward-thinking organizations in the B2B space. We have the broadest lens on emerging technologies, making us adept at co-creating breakthrough growth for clients.
Earlier this year, we made an official transformation into one of America’s best management consulting firms according to a survey conducted by Forbes.
The B2B economy is witnessing its emergence $25 trillion of new revenue streams replacing existing revenue streams in this decade alone. We work with clients on development programs, helping them monetize it $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy in Execution, Market Share Gain, Account Activation and Thought Leadership Marketing.
Based on the ‘GIVE Growth’ principle, we work with many Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our ideas and strategies are shaped by our industry experts, our ground-breaking AI-powered Market Intelligence Cloud, and years of research. KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates the analysis of connections across a set of applications, helping customers see the entire ecosystem and understand the revenue changes happening in their industry.
Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, Florida 33445 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit our Website:
